CompletedPhase 3NCT00930176
A Study Investigating Treatment Factor X in People With Factor X Deficiency
Studying Congenital factor X deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Bio Products Laboratory
- Principal Investigator
- Amy Shapiro, DrCo-Medical Director, Indiana Hemophilia and Thrombosis Center, 8402 Harcourt Road, Suite 420, Indianapolis, IN46260, USA
- Intervention
- Human Coagulation FACTOR X(biological)
- Enrollment
- 16 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2010 – 2013
Study locations (14)
- UCSF School of Medicine, San Francisco, California, United States
- Indiana Hemophilia & Thrombosis Center, Indianapolis, Indiana, United States
- Dr. William Mitchell New York Blood Center, Weill Cornell Medical College, New York, New York, United States
- Dr Gunter Auerswald, Bremen, Germany
- Dr. Bermejo, Cáceres, Spain
- Dr Maite Alvarez, Madrid, Spain
- Cukurova University Hospital, Balcali, Adana, Turkey (Türkiye)
- Ministry of Health Istanbul Goztepe Training & Research Hospital, Göztepe, Istanbul, Turkey (Türkiye)
- Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey (Türkiye)
- Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turkey (Türkiye)
- Prof. Kavakli, Izmir, Turkey (Türkiye)
- Prof. Oner, Van, Turkey (Türkiye)
- Dr. Sue Pavord, Leicester, United Kingdom
- Dr. Steve Austin, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00930176 on ClinicalTrials.gov